CardiorenalSyndrome:Classification,Pathophysiology,Diagnosis,andTreatmentStrategies
SGLT-2Inhibitors
SGLT-2inhibitorsareoneofthelatestclassesofglucose-loweringtherapiesavailable.OneSGLT-2inhibitor,empagliflozin,demonstratedimpressiveresultsinthemulticenterrandomizedcardiovascularsafetytrialEMPA-REGOUTCOME(EmpagliflozinCardiovascularOut